CytomX Therapeutics (CTMX) Provides Business Update and Outlines 2023 Goals
Go back to CytomX Therapeutics (CTMX) Provides Business Update and Outlines 2023 Goals| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.40 +0.13 (3.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.27 | 52 Week High | $24.68 | |||
| Open | $3.27 | 52 Week Low | $9.10 | |||
| Day High | $3.48 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $0.00 | |||
| Volume | 28,894,579 | |||||
